Abstract
We have developed the recombinant baculovirus pseudotyped with vesicular stomatitis virus (VSV) G protein. The VSV-G gene was under the control of the polyhedrin promoter so that it was expressed at high levels in infected insect cells but not in mammalian cells. The presence of VSV-G protein in purified baculovirus preparations was confirmed by Western analysis. This recombinant baculovirus also carried human AFP (α-fetoprotein) promoter for hepatocyte-specific gene expression. After an in vitro infection by a recombinant baculovirus carrying the luciferase gene under the control of human AFP promoter/enhancer (BacG-AFP-Luc+), the luciferase gene was expressed in AFP-producing Huh7, Hep3B, and HepG2 cell lines, but not in AFP-nonproducing cell lines. BacG-AFP-Luc+ transduced with human hepatoma cells in vitro at an efficiency about fivefold greater than the recombinant baculovirus lacking VSV-G (the virus Bac-AFP-Luc+). The utilization of the AFP promoter/enhancer in a baculovirus vector could provide benefits in gene therapy applications.
| Original language | English |
|---|---|
| Pages (from-to) | 444-450 |
| Number of pages | 7 |
| Journal | Biochemical and Biophysical Research Communications |
| Volume | 289 |
| Issue number | 2 |
| DOIs | |
| State | Published - 30 Nov 2001 |
Bibliographical note
Funding Information:This work was supported by Grant R01-2001-00150 from the Korea Science and Engineering Foundation.
Keywords
- Recombinant baculovirus
- VSV G
- α-feto-protein promoter